Broxil®
125 mg / 5 mL | Powder for oral suspension

From August 1, 2025 Broxil® 125 mg / 5 mL, powder for oral suspension is fully reimbursed by the health insurance. For this reason the reimbursement scheme for Broxil® 125 mg / 5 mL, powder for oral suspension terminates the 1st of August.
| Dose | 125 mg / 5 mL |
| Type | Powder for oral suspension |
| Active ingredient | FENETICILLIN (AS FENETICILLIN POTASSIUM) |
Now that the reimbursement scheme for Broxil® 125 mg / 5 mL, powder for oral suspension will be terminated, claims with an issue date before August 1, 2025 can be submitted until December 31, 2025. After that, no more claims can be processed.
The Personal Contribution demonstrably payed to the health insurer for Broxil® 125 mg / 5 mL, powder for oral suspension, is eligible for reimbursement via TBR Nederland with the exception of the first 2 containers and up to a maximum of € 250,- per patient per year. The arrangement applies from August 1 2020 and only from the 3rd container.
Only patients or their carer can submit a claim for the Personal Contribution paid for Broxil® 125 mg / 5 mL, powder for oral suspension online or by post. Online will be the fastest option. Pharmacists cannot submit claims on behalf of the patient for this medicine.
Claims with an issue date before the 1st of August 2025 can be processed by TBR Nederland until December 31, 2025.
Patients can claim online and will receive their reimbursement within 5 working days.
Patients can claim by post and will receive their reimbursement within 15 working days.
Please mail the Claim Form and attachments to:
TBR Nederland
Postbus 8011
1180 LA Amstelveen
If you need any assistance please read our Frequently Asked Questions.
Still does not work? Please contact our Servicedesk via e-mail or call the Broxil® service-number 088-0026712.
Quickly check the maximum contribution you have to pay for your medicine